The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer
Fjermeros, Kamilla, Ghannoum, Salim, Geisler, Stephanie B, Bhargava, Sameer, Tahiri, Andliena, Klajic, Jovana, Lüders, Torben, Fongård, Marie, Nawaz, Meh Sameen, Bosnjak-Olsen, Tatjana, Buvarp, Unn-Cathrin Edvardsen, Johanna Rosenskiold, Aino Katri, Nguyen, Nam Thi, Sletbak, Tone Tysko, Seyedzadeh, Manouchehr, Selsås, Knut, Porojnicu, Alina Carmen, Skjerven, Helle Kristine, Hovda, Tone, Sahlberg, Kristine Kleivi, Torland, Lilly Anne, Lyngra, Marianne, Hammarström, Clara Louise, Hönigsperger, Elma Bahonjic, Noone, John Christopher, Mathiassen, Silje, Hurtado, Antoni, Goel, Shom, Koff, Andrew, Tekpli, Xavier, Kristensen, Vessela N, Geisler, Jürgen
Published in Future oncology (London, England) (29.07.2024)
Published in Future oncology (London, England) (29.07.2024)
Get more information
Journal Article